Varespladib clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How each study uses varespladib is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
- Varespladib
- 2
Studies by the year they started
3 studies that test it; most in 2006 (1)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2012 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 2
- 3
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 3 · Other 0
Anthera Pharmaceuticals (2) · Ophirex, Inc. (1)
Studies
Open first, then newest update. How each study uses varespladib is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Study of Varespladib in Patients Hospitalized With Severe COVID-19TerminatedPhase 2Ophirex, Inc.NCT04969991Written as Varespladib
- IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest SyndromeCompletedPhase 2Anthera PharmaceuticalsNCT00434473Written as A-001
- A Study of Varespladib Infusion in Subjects With Sickle Cell Disease.TerminatedPhase 2Anthera PharmaceuticalsNCT01522196Written as Varespladib
Codes
What other systems call varespladib · ClinicalTrials.gg INT004139
- MeSH (NLM) C117948varespladibOne source NLM
- UNII (FDA) 2Q3P98DATHVARESPLADIBConfirmed FDA, NLM, Wikidata
- Wikidata Q7915613varespladibConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152832VarespladibOne source FDA
- DrugBank DB11909One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C117948 | varespladib | One source NLM |
| UNII (FDA) | 2Q3P98DATH | VARESPLADIB | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7915613 | varespladib | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152832 | Varespladib | One source FDA |
| DrugBank | DB11909 | — | One source Wikidata |
Also registered as varespladib sodium (UNII F6M52CDT0W).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.